Interim Visits is an online quarterly magazine that focuses on clinical research. Here you will find articles for those interested in learning more about clinical research, those considering participating in clinical trials, and clinical research professionals. We named the magazine Interim Visits because most of the data from a clinical trial is obtained, reviewed and verified during the interim visits when the data is reviewed and verified.

For more information, go to https://interimvisits.com/

Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance abuse, pain, cardiometabolic disorders, infectious diseases and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis, medical writing, monitoring as well as site feasibility and management for multi-site trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients. For more information, please visit https://sponsors.drvince.com/

QurCan Therapeutics, a University of Toronto spin-off biotech company, has developed a novel hybrid polymer-lipid nanoparticle technology called TERP platform, that enables non-immunogenic and CNS delivery of RNA molecules. QurCan is leveraging this disruptive TERP nanoparticle technology to advance innovative nucleotide therapeutics for individuals affected by genetically driven neurodegenerative diseases. For more information, please visit www.qurcan.com

Diligent Pharma is redefining vendor qualification and management within the clinical trial landscape through its tech-enabled, centralized quality and risk management platform. By integrating regulatory compliance expertise with a secure technology solution, Diligent provides a one-stop resource for managing vendor discovery, risk assessment, selection, and oversight activities. The Diligent platform, firmly rooted in the ICH Vendor Risk Management Framework, houses qualification packages and risk assessments for hundreds of vendors across 32 clinical trial service categories. Global regulatory authorities accept Diligent's centralized model as a valid approach to vendor qualification and oversight, allowing sponsors to save significant time by eliminating redundant steps through a system that ensures compliance and supports smarter, data-informed decision-making. For more information, go to www.diligentpharma.com.

TrialX is a clinical research and space health informatics company headquartered in New York City. From launching the first clinical trials app on Google Health in 2008, to powering online patient recruitment and research data collection for space missions, TrialX is empowering clinical research here on earth and beyond. Our offerings include Patient Recruitment Management - an all-in-one platform to simplify and accelerate clinical trial awareness, engagement and recruitment, and Remote Data Collection - a fully scalable eCOA/ePRO solution for global clinical trials. For more information, go to https://www.trialx.com/

InnoMedica is a ground-breaking Swiss biotech with the mission to enhance therapies for diseases with great unmet therapeutic needs through further development and new applications of our patented nanotechnology. Our nanotechnology platform is based on particularly small and uniform liposomes with an intelligent surface structure, making medical use of the body's natural logistics for the distribution of molecules. This allows the packaging of active ingredients which cannot reach the target in sufficient quantities or cause severe side effects when applied in high dosages. InnoMedica has applied our proprietary delivery platform to develop treatments for diseases and conditions in different therapeutic areas, with the objective of significantly improving the standard of care for patients with unmet needs.  For more information, visit https://innomedica.com/en/

For more information, visit https://www.asahi-kasei.com/

We are an entrepreneurial startup with innovative ideas that aim to contribute to solutions that will improve the quality of life. Our products are designed to help improve the health of the most vulnerable and in-need individuals by offering remote patient monitoring digital healthcare solutions for therapeutic management and Clinical Trials. For more information, go to: https://www.rxkeeper.com/

Topography Health is rethinking the entire research ecosystem, creating a more comprehensive platform to enhance care options for patients and delivering high quality evidence for sponsors. For more information, go to https://www.jointopo.com/.

RealTime eClinical Solutions is a leading eClinical technology provider reshaping the landscape of clinical trials with its comprehensive eClinical platform. Purpose-built for clinical research sites, site networks, AMCs, sponsors, and CROs, the platform goes beyond traditional CTMS to empower research and business workflows for modern-day clinical trials from trial award and study start-up through to trial execution. RealTime helps organizations manage the research and business of clinical trials, together, with software solutions including CTMS, eReg/eISF, eSource, participant payments (SitePay/GlobalPay), engagement solutions (Text, eConsent, and MyStudyManager™ Participant Portal), and Devana for pipeline management, business intelligence, and process and performance metrics. For more information, go to https://realtime-eclinical.com/.

RxE2 is entirely revolutionizing how clinical trials are conducted by utilizing, for the first time ever, community pharmacists, powered by our cutting-edge technology that provides patient recruitment, dispensing, counseling, and operational services to the pharmaceutical and biotech industries. For more information, go to https://www.rxe2.com/.

OxSonics is a pioneering clinical-stage company on a mission to transform cancer treatment with its breakthrough SonoTran® technology, utilising Innovative proprietary sonosensitive particles, co-administered with anti-cancer drugs, and “activated” by a novel ultrasound device. This enhances the delivery of oncology drugs into solid tumours, improving efficacy and/or reducing off-target toxicity. To learn more please visit: https://oxsonics.com/